The drugmaker’s decision to sell a generic version comes with the industry under pressure to do something about rising list prices.
Published: March 4, 2019 at 01:00AM
from NYT Health https://ift.tt/2ITf1Dt
The drugmaker’s decision to sell a generic version comes with the industry under pressure to do something about rising list prices.
Published: March 4, 2019 at 01:00AM
from NYT Health https://ift.tt/2ITf1Dt